Novartis (NVS) Cosentyx gains positive CHMP opinion for hidradenitis suppurativa streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
26.04.2023 - Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade Committee for Medicinal Products for Human Use (CHMP) opinion based on robust Phase III data showing Cosentyx (secukinumab) provided . Seite 1
For every 10,000 children who received one head CT examination, about one radiation-induced brain cancer is expected during the 5–15 years following the CT examination, researchers warn.